ClinicalTrials.Veeva

Menu

Modulation of Cortical Brain Activity During Attentional Control

N

National Scientific and Technological Research Council (CONICET)

Status

Enrolling

Conditions

Fibromyalgia
Chronic Pain
Rumination

Treatments

Other: Positive sham neurofeedback
Other: Negative sham neurofeedback
Other: Control

Study type

Observational

Funder types

Other

Identifiers

NCT06748976
IS004817

Details and patient eligibility

About

The goal of this study is to determine whether an open-loop sham neurofeedback system can effectively modulate EEG alpha rhythms, which are associated with attentional control. The main questions it aims to answer are:

Does positive sham neurofeedback lead to a decrease in relative EEG alpha power compared to a control condition without feedback?

Researchers will compare the effects of positive and negative sham-neurofeedback conditions to a control condition without feedback to assess the system's impact on alpha rhythm modulation. Participants will:

Experience three conditions (positive sham-neurofeedback, negative sham-neurofeedback, and no feedback) within a virtual reality environment.

Undergo EEG recordings to measure changes in alpha power as a marker of attentional resource allocation.

Provide written informed consent and complete the study following ethical guidelines.

This study seeks to explore the potential of open-loop feedback systems to enhance attentional control by modulating alpha rhythm.

Full description

Attention is a vital cognitive process that enables selective focus on behaviourally relevant information. A perceived lack of attentional control has been linked to mental disorders such as depression and anxiety, often manifesting through maladaptive coping strategies like rumination. As a trainable cognitive skill, attentional control can be enhanced through learning processes, particularly when reinforced by positive feedback within a classical operant conditioning framework. EEG studies have demonstrated that decreases in alpha rhythm power are associated with increased attentional resource allocation. While neurofeedback systems, especially those targeting alpha rhythms, typically rely on closed-loop modulation during attentional tasks, the impact of open-loop feedback on EEG alpha modulation remains unexplored. This study aims to determine whether an open-loop feedback system can effectively modulate EEG alpha rhythms, as a marker correlate of attentional control. The investigators propose a within-subject experiment where participants will experience positive and negative sham neurofeedback conditions, as well as a control condition with no feedback, all within a virtual reality environment. The investigators hypothesize that relative EEG alpha power will decrease in the positive sham neurofeedback condition compared to the control condition, reflecting a meaningful increase in attentional resource allocation.

Enrollment

35 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults aged between 18 and 60 years.
  • Normal or corrected vision.
  • Ability to provide written informed consent.

Exclusion criteria

  • Diagnosed with photosensitive epilepsy.
  • Significant hearing loss or diagnosed hearing impairment.
  • Current psychiatric illness or disorder.
  • History of migraines or chronic headaches.
  • History of substance or alcohol abuse.
  • Currently pregnant.
  • Discomfort with using a virtual reality headset, assessed during a pilot session.

Trial design

35 participants in 1 patient group

Healthy
Description:
Volunteers: Adults aged 18-60 years with normal or corrected vision, no clinical history of photosensitive epilepsy, psychiatric disorders, significant hearing loss, migraines, or substance abuse. Interventions: Positive sham-neurofeedback Negative sham-neurofeedback Control (no feedback)
Treatment:
Other: Control
Other: Negative sham neurofeedback
Other: Positive sham neurofeedback

Trial contacts and locations

1

Loading...

Central trial contact

José Alberto Biurrun Manresa, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems